Moyamoya disease during pregnancy and childbirth

Moyamoya disease (MMD) is a chronic vasculopathy characterized by progressive bilateral stenosis and occlusion of the terminal portion of the internal carotid artery (ICA) and the presence of an abnormal vascular network at the base of the brain, termed Moyamoya vessels (MMV). The main presentations...

Full description

Bibliographic Details
Main Authors: Ioana-Elena Tarabasanu-Mihaila, Francesca Gabriela Paslaru, Alexandru Catalin Paslaru, Nicolae Gica, Gheorghe Peltecu, Anca Maria Panaitescu
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2022-06-01
Series:Romanian Journal of Neurology
Subjects:
Online Access:https://rjn.com.ro/articles/2022.2/RJN_2022_2_Art-06.pdf
_version_ 1798036925459726336
author Ioana-Elena Tarabasanu-Mihaila
Francesca Gabriela Paslaru
Alexandru Catalin Paslaru
Nicolae Gica
Gheorghe Peltecu
Anca Maria Panaitescu
author_facet Ioana-Elena Tarabasanu-Mihaila
Francesca Gabriela Paslaru
Alexandru Catalin Paslaru
Nicolae Gica
Gheorghe Peltecu
Anca Maria Panaitescu
author_sort Ioana-Elena Tarabasanu-Mihaila
collection DOAJ
description Moyamoya disease (MMD) is a chronic vasculopathy characterized by progressive bilateral stenosis and occlusion of the terminal portion of the internal carotid artery (ICA) and the presence of an abnormal vascular network at the base of the brain, termed Moyamoya vessels (MMV). The main presentations of MMD are ischemia and hemorrhage, and diagnosis is done via angiography. Cerebral events were reported in 5.1% of pregnancies of MMD diagnosed mothers, in Japan. In the case of MMD diagnosis due to cerebrovascular events during gestation, 34.7% of patients presented with an ischemic event, while 69.5% suffered from hemorrhage. During gestation, hemorrhagic events were found to occur mostly antepartum, after 24 weeks of gestation, while cerebral infarction peaked 3-7 days after delivery. No treatment has been found to halt or reverse the progress of the disease. Interventions focus on reducing the risk of stroke and cognitive disfunction as a result of ischemia. In the case of pregnant women suffering hemorrhage due to MMD, conservative treatment, as well as ventricle puncture and drainage were to be efficient, and did not severely impact the child. When diagnosed before pregnancy occurs, MMD under treatment does not pose a significantly increased risk of complications, compared to pregnancies in unaffected women. No evidence suggests that MMD is a contraindication for pregnancy.
first_indexed 2024-04-11T21:19:39Z
format Article
id doaj.art-a103f347b4e6450b8c4c5637df30b8ed
institution Directory Open Access Journal
issn 1843-8148
2069-6094
language English
last_indexed 2024-04-11T21:19:39Z
publishDate 2022-06-01
publisher Amaltea Medical Publishing House
record_format Article
series Romanian Journal of Neurology
spelling doaj.art-a103f347b4e6450b8c4c5637df30b8ed2022-12-22T04:02:42ZengAmaltea Medical Publishing HouseRomanian Journal of Neurology1843-81482069-60942022-06-0121212412710.37897/RJN.2022.2.6Moyamoya disease during pregnancy and childbirthIoana-Elena Tarabasanu-Mihaila0Francesca Gabriela Paslaru1Alexandru Catalin Paslaru2Nicolae Gica3Gheorghe Peltecu4Anca Maria Panaitescu5“Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaNeurosurgical Department, “Bagdasar-Arseni” Clinical Emergency Hospital, Bucharest, RomaniaDepartment of Physiology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; “Dr. Victor Gomoiu” Children’s Clinical Hospital, Bucharest, RomaniaFilantropia Clinical Hospital, Bucharest, Romania; Department of Obstetrics and Gynecology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaFilantropia Clinical Hospital, Bucharest, Romania; Department of Obstetrics and Gynecology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaFilantropia Clinical Hospital, Bucharest, Romania; Department of Obstetrics and Gynecology, “Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaMoyamoya disease (MMD) is a chronic vasculopathy characterized by progressive bilateral stenosis and occlusion of the terminal portion of the internal carotid artery (ICA) and the presence of an abnormal vascular network at the base of the brain, termed Moyamoya vessels (MMV). The main presentations of MMD are ischemia and hemorrhage, and diagnosis is done via angiography. Cerebral events were reported in 5.1% of pregnancies of MMD diagnosed mothers, in Japan. In the case of MMD diagnosis due to cerebrovascular events during gestation, 34.7% of patients presented with an ischemic event, while 69.5% suffered from hemorrhage. During gestation, hemorrhagic events were found to occur mostly antepartum, after 24 weeks of gestation, while cerebral infarction peaked 3-7 days after delivery. No treatment has been found to halt or reverse the progress of the disease. Interventions focus on reducing the risk of stroke and cognitive disfunction as a result of ischemia. In the case of pregnant women suffering hemorrhage due to MMD, conservative treatment, as well as ventricle puncture and drainage were to be efficient, and did not severely impact the child. When diagnosed before pregnancy occurs, MMD under treatment does not pose a significantly increased risk of complications, compared to pregnancies in unaffected women. No evidence suggests that MMD is a contraindication for pregnancy.https://rjn.com.ro/articles/2022.2/RJN_2022_2_Art-06.pdfmoyamoya diseasepregnancybypass surgeryischemiahemorrhagic stroke
spellingShingle Ioana-Elena Tarabasanu-Mihaila
Francesca Gabriela Paslaru
Alexandru Catalin Paslaru
Nicolae Gica
Gheorghe Peltecu
Anca Maria Panaitescu
Moyamoya disease during pregnancy and childbirth
Romanian Journal of Neurology
moyamoya disease
pregnancy
bypass surgery
ischemia
hemorrhagic stroke
title Moyamoya disease during pregnancy and childbirth
title_full Moyamoya disease during pregnancy and childbirth
title_fullStr Moyamoya disease during pregnancy and childbirth
title_full_unstemmed Moyamoya disease during pregnancy and childbirth
title_short Moyamoya disease during pregnancy and childbirth
title_sort moyamoya disease during pregnancy and childbirth
topic moyamoya disease
pregnancy
bypass surgery
ischemia
hemorrhagic stroke
url https://rjn.com.ro/articles/2022.2/RJN_2022_2_Art-06.pdf
work_keys_str_mv AT ioanaelenatarabasanumihaila moyamoyadiseaseduringpregnancyandchildbirth
AT francescagabrielapaslaru moyamoyadiseaseduringpregnancyandchildbirth
AT alexandrucatalinpaslaru moyamoyadiseaseduringpregnancyandchildbirth
AT nicolaegica moyamoyadiseaseduringpregnancyandchildbirth
AT gheorghepeltecu moyamoyadiseaseduringpregnancyandchildbirth
AT ancamariapanaitescu moyamoyadiseaseduringpregnancyandchildbirth